DarioHealth Corp. Files Definitive Proxy Statement

Ticker: DRIO · Form: DEF 14A · Filed: Mar 10, 2025 · CIK: 1533998

Dariohealth CORP. DEF 14A Filing Summary
FieldDetail
CompanyDariohealth CORP. (DRIO)
Form TypeDEF 14A
Filed DateMar 10, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, shareholder-meeting

TL;DR

DarioHealth proxy filed. Vote on directors & pay soon.

AI Summary

DarioHealth Corp. filed its definitive proxy statement on March 10, 2025, for its annual meeting on April 28, 2025. The filing details information related to the company's governance and shareholder matters, including the election of directors and executive compensation. DarioHealth Corp. was formerly known as LabStyle Innovations Corp. until November 1, 2011.

Why It Matters

This filing provides shareholders with crucial information needed to vote on company matters, influencing the direction of DarioHealth Corp. and its executive leadership.

Risk Assessment

Risk Level: low — This is a standard regulatory filing (DEF 14A) providing information to shareholders, not indicating new operational risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing detailed information on matters to be voted upon.

When is the DarioHealth Corp. annual meeting scheduled?

The annual meeting for DarioHealth Corp. is scheduled for April 28, 2025.

What was DarioHealth Corp.'s former name?

DarioHealth Corp. was formerly known as LabStyle Innovations Corp.

What is the business address of DarioHealth Corp.?

The business address of DarioHealth Corp. is 322 W 57TH ST. #33B, New York, NY 10019.

What is the SIC code for DarioHealth Corp.?

The Standard Industrial Classification (SIC) code for DarioHealth Corp. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 10, 2025 regarding DarioHealth Corp. (DRIO).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing